<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35548670</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1178-2390</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>15</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Journal of multidisciplinary healthcare</Title>
          <ISOAbbreviation>J Multidiscip Healthc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Added Value of a Multidisciplinary Clinic for Systemic Autoinflammatory Diseases.</ArticleTitle>
        <Pagination>
          <StartPage>999</StartPage>
          <EndPage>1010</EndPage>
          <MedlinePgn>999-1010</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2147/JMDH.S351546</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Systemic autoinflammatory diseases (SAID) are characterized by inappropriate activation of the innate immune system and include not only monogenic periodic fever syndromes but also multifactorial conditions. As SAID are rare and represent a diagnostic challenge, a multidisciplinary approach is important to ensure successful diagnosis and adequate follow-up of these patients.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To describe the organization of our multidisciplinary SAID clinic and to characterize our clinical experience, highlighting the benefits of multidisciplinary team management.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Our SAID clinic takes place monthly and is managed by pediatric rheumatologists closely collaborating with pediatricians specialized in infectious diseases and immunodeficiencies and one medical geneticist. Patients' data are systematically incorporated in the Rheumatic Diseases Portuguese Register (Reuma.pt). Biological samples are stored in a biobank. We describe our clinical experience based on SAID patients registered into Reuma.pt/SAID between July 2011 and June 2020.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We have registered 176 patients, with a median age of disease onset of 3.1 ± 4.4 years and median age at disease diagnosis of 4.7 ± 4.0 years. Most patients were diagnosed with periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome (PFAPA) (n=133), 20 with undefined SAID (uSAID) and 13 with monogenic SAID, including familial Mediterranean fever (FMF) (n=5), tumor necrosis factor receptor-associated periodic syndrome (TRAPS) (n=1), cryopyrin-associated periodic disease (CAPS) (n=1), and hyperimmunoglobulin D syndrome/mevalonate kinase deficiency (HIDS/MKD) (n=2). A genetic test was performed in 31 patients (18%), and in 26% of these a mutation responsible for the phenotype was found. Thirty-four patients (19%) achieved remission.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">FMF was the most common monogenic SAID and the percentage of patients with an identified causal mutation was low. A structured electronic clinical record coupled with a biobank and a multidisciplinary approach are crucial to ensure successful diagnosis and adequate follow-up of these patients.</AbstractText>
          <CopyrightInformation>© 2022 Zinterl et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zinterl</LastName>
            <ForeName>Carolina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Rheumatology Unit, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Costa-Reis</LastName>
            <ForeName>Patrícia</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Rheumatology Unit, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Pediatrics Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Esteves</LastName>
            <ForeName>Isabel Castro</ForeName>
            <Initials>IC</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatrics Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marques</LastName>
            <ForeName>José Gonçalo</ForeName>
            <Initials>JG</Initials>
            <Identifier Source="ORCID">0000-0001-7982-6697</Identifier>
            <AffiliationInfo>
              <Affiliation>Pediatrics Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sousa</LastName>
            <ForeName>Ana Berta</ForeName>
            <Initials>AB</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatrics Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Basic Immunology, Faculty of Medicine, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fonseca</LastName>
            <ForeName>João Eurico</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oliveira Ramos</LastName>
            <ForeName>Filipa</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Rheumatology Unit, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Multidiscip Healthc</MedlineTA>
        <NlmUniqueID>101512691</NlmUniqueID>
        <ISSNLinking>1178-2390</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">pediatrics</Keyword>
        <Keyword MajorTopicYN="N">rheumatology</Keyword>
        <Keyword MajorTopicYN="N">systemic autoinflammatory syndromes</Keyword>
      </KeywordList>
      <CoiStatement>Dr Carolina Zinterl reports grants from Novartis, during the conduct of the study. Prof. Dr. Patrícia Costa-Reis reports personal fees from Kyowa Kirin, outside the submitted work. The authors report no other conflicts of interest in this work. The abstract of this paper was presented at the 23rd Portuguese Rheumatology Congress as a poster presentation with interim findings. The poster’s abstract was published in “Poster Abstracts” in Acta reumatologica portuguesa: https://www.arprheumatology.com/archive_detail.php?id=237.38 This project had the financial contribution of Novartis.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>11</Hour>
          <Minute>28</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35548670</ArticleId>
        <ArticleId IdType="pmc">PMC9081005</ArticleId>
        <ArticleId IdType="doi">10.2147/JMDH.S351546</ArticleId>
        <ArticleId IdType="pii">351546</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Thomas KT, Feder JHM, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999;135(1):15–21. doi:10.1016/S0022-3476(99)70321-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-3476(99)70321-5</ArticleId>
            <ArticleId IdType="pubmed">10393598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010;140(6):784–790. doi:10.1016/j.cell.2010.03.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2010.03.002</ArticleId>
            <ArticleId IdType="pmc">PMC3541025</ArticleId>
            <ArticleId IdType="pubmed">20303869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russo RA, Brogan PA. Monogenic autoinflammatory diseases. Rheumatology. 2014;53(11):1927–1939. doi:10.1093/rheumatology/keu170</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/keu170</ArticleId>
            <ArticleId IdType="pubmed">24831056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toplak N, Frenkel J, Ozen S, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis. 2012;71(7):1177–1182. doi:10.1136/annrheumdis-2011-200549</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2011-200549</ArticleId>
            <ArticleId IdType="pubmed">22377804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rowczenio DM, Lachmann HJ. How to prescribe a genetic test for the diagnosis of autoinflammatory diseases?
La Presse Méd. 2019;48(1):e49–e59. doi:10.1016/j.lpm.2018.08.015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lpm.2018.08.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kallinich T, Gattorno M, Grattan C, et al. Unexplained recurrent fever: when is autoinflammation the explanation?
Allergy. 2013;68(3):285–296. doi:10.1111/all.12084</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/all.12084</ArticleId>
            <ArticleId IdType="pubmed">23330689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gattorno M, Hofer M, Federici S, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019;78(8):1025–1032. doi:10.1136/annrheumdis-2019-215048</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2019-215048</ArticleId>
            <ArticleId IdType="pubmed">31018962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Jesus AA, Goldbach-Mansky R. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol. 2013;147(3):155–174. doi:10.1016/j.clim.2013.03.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clim.2013.03.016</ArticleId>
            <ArticleId IdType="pmc">PMC3769788</ArticleId>
            <ArticleId IdType="pubmed">23711932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009;27:621–668. doi:10.1146/annurev.immunol.25.022106.141627</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.immunol.25.022106.141627</ArticleId>
            <ArticleId IdType="pmc">PMC2996236</ArticleId>
            <ArticleId IdType="pubmed">19302049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ugwumadu L, Chakrabarti R, Williams-Brown E, et al. The role of the multidisciplinary team in the management of deep infiltrating endometriosis. Gynecol Surg. 2017;14(1):1–4. doi:10.1186/s10397-017-1018-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s10397-017-1018-0</ArticleId>
            <ArticleId IdType="pmc">PMC5388728</ArticleId>
            <ArticleId IdType="pubmed">28458626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cobo-Ibáñez T, Villaverde V, Seoane-Mato D, et al. Multidisciplinary dermatology–rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review. Rheumatol Int. 2016;36(2):221–229. doi:10.1007/s00296-015-3377-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-015-3377-z</ArticleId>
            <ArticleId IdType="pubmed">26438388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canhao H, Faustino A, Martins F, Fonseca JE, Nero P, Branco JC. Reuma. pt-the rheumatic diseases Portuguese register. Acta Reumatol Port. 2011;36(1):45–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21483280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santos MJ, Canhão H, Faustino A, Fonseca JE. Reuma. pt–a case study. Acta Médica Portuguesa. 2016;29(2):83–84. doi:10.20344/amp.7243</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.20344/amp.7243</ArticleId>
            <ArticleId IdType="pubmed">27234945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martorana D, Bonatti F, Mozzoni P, Vaglio A, Percesepe A. Monogenic autoinflammatory diseases with Mendelian inheritance: genes, mutations, and genotype/phenotype correlations. Front Immunol. 2017;8(344). doi:10.3389/fimmu.2017.00344</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.00344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welzel T, Kuemmerle-Deschner JB. Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today?
J Clin Med. 2021;10(1):128. doi:10.3390/jcm10010128</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm10010128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piram M, Koné-Paut I, Lachmann HJ, et al. Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis. 2014;73(12):2168–2173. doi:10.1136/annrheumdis-2013-203666</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2013-203666</ArticleId>
            <ArticleId IdType="pmc">PMC4251184</ArticleId>
            <ArticleId IdType="pubmed">24026675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vanoni F, Caorsi R, Aeby S, et al. Towards a new set of classification criteria for PFAPA syndrome. Pediatric Rheumatol. 2018;16(1):1–4. doi:10.1186/s12969-018-0277-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12969-018-0277-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wekell P. Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome–PFAPA syndrome. La Presse Médicale. 2019;48(1):e77–e87. doi:10.1016/j.lpm.2018.08.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lpm.2018.08.016</ArticleId>
            <ArticleId IdType="pubmed">30683466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Georgin-Lavialle S, Fayand A, Rodrigues F, Bachmeyer C, Savey L, Grateau G. Autoinflammatory diseases: state of the art. La Presse Méd. 2019;48(1):e25–e48. doi:10.1016/j.lpm.2018.12.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lpm.2018.12.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao Q, Lacbawan F, Li J. Adult autoinflammatory disease frequency and our diagnostic experience in an adult autoinflammatory clinic. Paper presented at: Seminars in arthritis and rheumatism; 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008;87(6):301–310. doi:10.1097/MD.0b013e318190cfb7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e318190cfb7</ArticleId>
            <ArticleId IdType="pubmed">19011501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grandemange S, Cabasson S, Sarrabay G, et al. Clinical dose effect and functional consequences of R92Q in two families presenting with a TRAPS/PFAPA‐like phenotype. Mol Genet Genomic Med. 2017;5(2):110–116. doi:10.1002/mgg3.229</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mgg3.229</ArticleId>
            <ArticleId IdType="pmc">PMC5370222</ArticleId>
            <ArticleId IdType="pubmed">28361096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ravet N, Rouaghe S, Dode C, et al. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis. 2006;65(9):1158–1162. doi:10.1136/ard.2005.048611</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ard.2005.048611</ArticleId>
            <ArticleId IdType="pmc">PMC1798274</ArticleId>
            <ArticleId IdType="pubmed">16569687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Savic S, Dickie LJ, Battellino M, McDermott MF. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol. 2012;24(1):103–112. doi:10.1097/BOR.0b013e32834dd2d5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0b013e32834dd2d5</ArticleId>
            <ArticleId IdType="pubmed">22089100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karacan İ, Balamir A, Uğurlu S, et al. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study. Rheumatol Int. 2019;39(5):911–919. doi:10.1007/s00296-019-04252-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-019-04252-5</ArticleId>
            <ArticleId IdType="pubmed">30783801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Federici S, Sormani MP, Ozen S, et al. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015;74(5):799–805. doi:10.1136/annrheumdis-2014-206580</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2014-206580</ArticleId>
            <ArticleId IdType="pubmed">25637003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoffels M, Kastner DL, Dogs O. New tricks: monogenic autoinflammatory disease unleashed. Annu Rev Genomics Hum Genet. 2016;17(1):245–272. doi:10.1146/annurev-genom-090413-025334</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-genom-090413-025334</ArticleId>
            <ArticleId IdType="pubmed">27362340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka N, Izawa K, Saito MK, et al. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study. Arthritis Rheum. 2011;63(11):3625–3632. doi:10.1002/art.30512</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.30512</ArticleId>
            <ArticleId IdType="pmc">PMC3498501</ArticleId>
            <ArticleId IdType="pubmed">21702021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rowczenio DM, Gomes SM, Aróstegui JI, et al. Late-onset cryopyrin-associated periodic syndromes caused by somatic NLRP3 mosaicism—UK single center experience. Front Immunol. 2017;8:1410. doi:10.3389/fimmu.2017.01410</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.01410</ArticleId>
            <ArticleId IdType="pmc">PMC5671490</ArticleId>
            <ArticleId IdType="pubmed">29163488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saito M, Nishikomori R, Kambe N, et al. Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients. Blood. 2008;111(4):2132–2141. doi:10.1182/blood-2007-06-094201</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2007-06-094201</ArticleId>
            <ArticleId IdType="pubmed">18063752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa K, Gonzalez-Roca E, Souto A, et al. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes. Ann Rheum Dis. 2015;74(3):603–610. doi:10.1136/annrheumdis-2013-204361</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2013-204361</ArticleId>
            <ArticleId IdType="pubmed">24326009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuemmerle-Deschner JB, Lohse P, Koetter I, et al. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome-description of a heterogeneous phenotype and response to treatment. Arthritis Res Ther. 2011;13(6):1–9. doi:10.1186/ar3526</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/ar3526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mensa-Vilaró A, García-Morato MB, de la Calle-martin O, et al. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases. J Allergy Clin Immunol. 2019;143(1):359–368. doi:10.1016/j.jaci.2018.09.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2018.09.009</ArticleId>
            <ArticleId IdType="pubmed">30273710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster HE, Minden K, Clemente D, et al. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2017;76(4):639–646. doi:10.1136/annrheumdis-2016-210112</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2016-210112</ArticleId>
            <ArticleId IdType="pubmed">27802961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh-Grewal D. Multidisciplinary paediatric rheumatology services in Australia and New Zealand. Med J Aust. 2017;206(2):96–97. doi:10.5694/mja16.00710</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5694/mja16.00710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leal I, Romão VC, Mano S, et al. A non-infectious uveitis multidisciplinary clinic in a tertiary referral center: clinical impact and added value. J Multidiscip Healthc. 2021;14:695. doi:10.2147/JMDH.S292981</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/JMDH.S292981</ArticleId>
            <ArticleId IdType="pmc">PMC7997415</ArticleId>
            <ArticleId IdType="pubmed">33790568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosell L, Wihl J, Hagberg O, Ohlsson B, Nilbert M. Function, information, and contributions: an evaluation of national multidisciplinary team meetings for rare cancers. Rare Tumors. 2019;11:2036361319841696. doi:10.1177/2036361319841696</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2036361319841696</ArticleId>
            <ArticleId IdType="pmc">PMC6506921</ArticleId>
            <ArticleId IdType="pubmed">31105919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zinterl C, Reis PC, Esteves IC, et al. The experience of a multidisciplinary clinic for systemic autoinflammatory diseases. Acta Reumatol Port. 2021;46(4):104.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
